HRP Streptavidin

Pricing & Availability
Other Names
Streptavidin-Horseradish Peroxidase, SAv-HRP
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Avail. Save
405210 1 ml 88€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-HRP is useful for detecting biotinylated antibodies, e.g., in ELISA, ELISPOT, IHC or Western blotting. For ELISA applications, HRP will act on soluble substrates, such as ABTS or TMB, to yield a colorimetric reaction. For ELISPOT or Western blotting applications, HRP will act on precipitating substrates, such as 4CN, to yield a colorimetric reaction.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human, Mouse, Rat, All Species
Formulation
Buffered solution containing bovine protein and preservatives (methylisothiazolone, bromonitrodioxane, and other active isothiazolones).
Preparation
Streptavidin is conjugated with horseradish peroxidase under optimal conditions.
Storage & Handling
This product is guaranteed for six months. The streptavidin-HRP solution should be stored undiluted between 2°C and 8°C. Avoid exposure to sodium azide.

This product has a shelf-life of 12 months or less. Please use our Expiration Lookup Tool to verify the expiration date of your lot of product
Application

ELISA - Quality tested
ELISPOT, WB, IHC - Reported in the literature

Recommended Usage

Each lot of this Streptavidin-HRP is quality control tested by ELISA assay. For ELISA or Western blot analysis, the reagent should be titrated between 1:1000 - 1:3000 to determine optimal conditions. For ELISPOT analysis, the reagent should be titrated between 1:500 - 1:1500 to determine optimal conditions. Avoid using biotin-containing solutions as diluents and solutions containing sodium azide. Sodium azide is an inhibitor of horseradish peroxidase. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Streptavidin-HRP is useful as a second step reagent for indirect enzymatic labelling, in conjunction with biotinylated primary antibodies. Sav-HRP is recommended for ELISA, ELISPOT and Western blotting, when used with the relevant substrate system.

Application References

(PubMed link indicates BioLegend citation)
  1. Li KJ, et al. 2006. J. Leukoc. Biol. doi:10.1189/jlb.1105668.PubMed
  2. Weldon S, et al. 2009. J. Immunol. 183:8148. PubMed
  3. Basnayake K, et al. 2010. J Am Soc Naphrol. 21:1165. PubMed
  4. Marder W, et al. 2011. Ann Rheum Dis. PubMed
  5. Cheng J, et al. 2012. Mol Biol Cell. 23:2891. PubMed
  6. Vishwakarma V, et al. 2012. Infect Immun. 80:3236. PubMed
  7. Sun X, et al. 2013. J. Immunol. 190:2536. PubMed
  8. Van Phan T, et al. 2013. Biochem Pharmacol. 85:1145. PubMed
  9. Ranganathan P, et al. 2013. J Rhematol. 40:129. PubMed
  10. Din Su, et al. 2013. Occup Med. PubMed
  11. Bulut GB, et al. 2013. Blood. 122:3964. PubMed
  12. Chia YL, et al. 2013. Antiviral Res. 3542:354. PubMed
  13. Ahn JM, et al. 2014. Mol Cell Proteomics. 13:30. PubMed
  14. Din SU, et al. 2014. Occup Med. 64:39. PubMed
  15. Balmer ML, et al. 2014. Sci Transl Med. 21:237. PubMed
  16. Klehmet J, et al. 2014. J Neurol Neurosurg Psychiatry. PubMed
  17. Wu CC, et al. 2014. Cancer Epidemiol. Biomarkers Prev. 23:1569. PubMed
  18. Peng JG, et al. 2014. J Virol. 88:8386. PubMed
  19. Chlon TM, et al. 2014. J Virol. 88:11315. PubMed
  20. Sadovskaya I, et al. 2014. Carbohydr Poly. 111:139. PubMed
  21. Liu T, et al. 2015. Infect Immun. 83:2011. PubMed
  22. Himmelein S, et al. 2015. J Virol. 89:5747. PubMed
  23. Dinter J, et al. 2015. J Mol Endocrinol. 54:205. PubMed
  24. Yang L, et al. 2015. J Immunol. 194:5635. PubMed
Product Citations
  1. Li K, et al. 2006. J Leukoc Biol . 80:350. PubMed
  2. Weldon S, et al. 2009. J Immunol. 183:8148. PubMed
  3. Basnayake K, et al. 2010. J Am Soc Nephrol. 1.684027778. PubMed
  4. Marder W, et al. 2011. Ann Rheum Dis. 70:1550. PubMed
  5. Cheng J, et al. 2012. Mol Biol Cell. 23:2891. PubMed
  6. Vishwakarma V, et al. 2012. Infect Immun . 80:3236. PubMed
  7. Sun X, et al. 2013. J Immunol. 190:2536. PubMed
  8. Phan T, et al. 2013. Biochem Pharmacol. 85:1145. PubMed
  9. Bulut G, et al. 2013. Blood. 122:3964. PubMed
  10. Chia Y, et al. 2013. Antiviral Res. 3542:354. PubMed
  11. Ahn J, et al. 2014. Mol Cell Proteomics. 13:30. PubMed
  12. Tidley S 2014. Occup Med. 64:39. PubMed
  13. Balmer M, et al. 2014. Sci Transl Med. 21:237. PubMed
  14. Klehmet J, et al. 2014. J Neurol Psychiatry. . PubMed
  15. Wu C, et al. 2014. Cancer Epidemiol Biomarkers Prev. 23:1569. PubMed
  16. Wu J 2014. J Virol. 88:8386. PubMed
  17. Chlon T, et al. 2014. J Virol. 88:11315. PubMed
  18. Sadovskaya I, et al. 2014. Carbohydr Polym. 111:139. PubMed
  19. Liu T, et al. 2015. Infect Immun . 83:2011. PubMed
  20. Himmelein S, et al. 2015. J Virol. 89:5747. PubMed
  21. Dinter J, et al. 2015. J Mol Endocrinol. 54:205. PubMed
  22. Shinohara M 2015. J Immunol. 194:5635. PubMed
  23. Zhang C, et al. 2015. J Surgical Res. 197: 301-306. PubMed
  24. Isernhagen A, et al. 2015. EMBO Mol Med. 7: 1480 - 1502. PubMed
  25. Hwang D, et al. 2016. PLoS One. 11: 0152522. PubMed
  26. Baerenwaldt A, et al. 2016. J Immunol. 196: 2561 - 2571. PubMed
  27. Parrish H, et al. 2016. Proc Natl Acad Sci U S A. 113: 3000 - 3005. PubMed
  28. Yen J, et al. 2015. J Leukoc Biol. 98: 689-702. PubMed
  29. Tu S, et al. 2015. Nature. 534:387-390. PubMed
  30. Czakai K, et al. 2016. Sci Rep. 6:27990. PubMed
  31. Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
  32. Brugiroux S, et al. 2016. Nat Microbiol. 2:16215. PubMed
  33. Ye F, et al. 2016. J Virol. 90: 9654 - 9663. PubMed
  34. MÜller A, et al. 2016. PLoS One. 11:e0168260. PubMed
  35. Tsanov K, et al. 2016. Nat Cell Biol. 19:60-67. PubMed
  36. Gendron D, et al. 2017. Pulm Pharmacol Ther. 10.1016/j.pupt.2017.03.010. PubMed
  37. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  38. Kiriakidis S, et al. 2017. Kidney International. 10.1016/j.kint.2017.03.008. PubMed
  39. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
  40. Hooper K, Kong W, Ganea D, et al. 2017. PLoS One. 12(6):e0179184. PubMed
  41. Gröschel C, et al. 2017. Sci Rep.. 10.1038/s41598-017-16147-1. PubMed
  42. Peng Y 2017. PLoS One. 10.1371/journal.pone.0188112. PubMed
  43. Gröschel C, et al. 2018. Front Immunol. 9:2665. PubMed
  44. Wang YH, et al. 2018. Oncol Lett. 16:6903. PubMed
  45. Cárdenas–Torres FI, et al. 2019. Medicina (Kaunas). 55:3. PubMed
  46. Simic MS, et al. 2019. Sci Adv. 5:eaaw0025. PubMed
  47. Kikuchi N, et al. 2019. Biol Pharm Bull. 42:57. PubMed
  48. Gamache J, et al. 2019. Nat Commun. 10:2479. PubMed
  49. Duan S, et al. 2019. J Clin Invest. 129:1387. PubMed
Publication Library

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 06.18.2019

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login / Register
Forgot your password? Reset password?
Create an Account